Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Oncologist|February 17, 2010
Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancerLee S Schwartzberg, Lee S Schwarzberg, Sandra X Franco, et al.
Breast Cancer Research and Treatment|March 23, 2019
Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patientsAlfredo Torres, Jeremy L Ramdial, Luis E Aguirre, et al.
Journal of Medical Case Reports|December 12, 2022
Multiple receptor conversions during the course of metastatic breast cancer therapy: a case report and review of the literatureYolcar Chamorro, Ana C Sandoval-Leon, Charles L Vogel, et al.
Breast Cancer Research and Treatment|June 27, 2002
Weekly paclitaxel in women age 65 and above with metastatic breast cancerEdith A Perez, Charles L Vogel, David H Irwin, et al.
Cancer Chemotherapy and Pharmacology|March 19, 2009
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancerOlivier Rixe, Sandra X Franco, Denise A Yardley, et al.
The Oncologist|May 24, 2013
An open-label safety study of lapatinib plus trastuzumab plus paclitaxel in first-line HER2-positive metastatic breast cancerFrancisco J Esteva, Sandra X Franco, Maura K Hagan, et al.
Annals of Surgical Oncology|May 3, 2002
Focused microwave phased array thermotherapy for primary breast cancerRobert A Gardner, Hernan I Vargas, Jerome B Block, et al.
Breast Cancer Research and Treatment|September 12, 2015
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literatureSimon B Zeichner, Stuart Herna, Aruna Mani, et al.
Pain|May 21, 2019
Testing a positive-affect induction to reduce verbally induced nocebo hyperalgesia in an experimental pain paradigmAndrew L Geers, Shane Close, Fawn C Caplandies, et al.
Clinical Breast Cancer|September 3, 2005
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumabRobert D Mass, Michael F Press, Steven Anderson, et al.
Pageof 4